Events & Presentations

Events & Presentations

Date Event Details Remind Me
Dec 9, 2019
8:00 PM EST
2019 R&D Update and ASH Data Review

Genmab will hold a brief update to discuss progress in our innovative pipeline as well as key product data presented during the American Society of Hematology (ASH) Annual Meeting.

The event will take place in Orlando, Florida and will be webcast live. Webcast details will be available via genmab.com closer to the date of the event.

This event is not an official program of the ASH Annual Meeting. 

Feb 12, 2020
Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors
Feb 19, 2020
Publication of the Annual Report for 2019
Mar 26, 2020
Annual General Meeting 2020
May 6, 2020
Publication of the Interim Report for the first quarter 2020 (after 5:00 PM CET)
Aug 12, 2020
Publication of the Interim Report for the first half 2020 (after 5:00 PM CET)
Nov 4, 2020
Publication of the Interim Report for the first nine months 2020 (after 5:00 PM CET)
Date Event Details
Nov 8, 2019
4:30 PM CET
Interactive Q&A Session with Genmab’s CEO
Nov 6, 2019
6:00 PM CET
First Nine Months of 2019 Financial Results Conference Call
Nov 6, 2019
Publication of the Interim Report for the first nine months 2019 (after 5:00 PM CET)
Aug 20, 2019
4:30 PM CEST
Interactive Q&A Session with Genmab's CEO
Aug 14, 2019
6:00 PM CEST
First Half 2019 Financial Results Conference Call
Aug 14, 2019
Publication of the Interim Report for the first half 2019 (after 5:00 PM CEST)
Jun 13 - Jun 16, 2019
24th European Hematology Association Annual Congress, Amsterdam, the Netherlands
May 31 - Jun 4, 2019
American Society of Clinical Oncology Annual Meeting, Chicago, IL, US
May 13, 2019
3:00 PM CEST
Interactive Q&A Session with Genmab's Senior Director, Investor Relations
May 8, 2019
6:00 PM CEST
First Quarter 2019 Financial Results Conference Call
May 8, 2019
5:00 PM CEST
Publication of the Interim Report for the first quarter 2019
Mar 29, 2019
Annual General Meeting 2019
Mar 4, 2019
4:00 PM CET
Interactive Q&A Session with Genmab's CEO
Feb 20, 2019
6:00 PM CET
2018 Full Year Financial Results Conference Call
Feb 20, 2019
5:00 PM CET
Publication of the Annual Report for 2018
Feb 14, 2019
Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors
Jan 9, 2019
3:30 PM PST
37th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, US
Dec 3, 2018
8:00 PM PST
Genmab's 2018 ASH Data Review

Genmab will hold a brief R&D Update focused on key product data that was presented during the ASH Annual Meeting. The event will be webcast live.

This meeting is NOT an official program of the ASH Annual Meeting

Dec 1 - Dec 4, 2018
American Society of Hematology Annual Meeting, San Diego, CA, US
Nov 21, 2018
3:00 PM CET
Interactive Q&A Session with Genmab's CEO
Nov 15, 2018
Jefferies European Healthcare Conference, London, UK
Nov 14, 2018
6:00 PM CET
First Nine Months 2018 Conference Call
Nov 14, 2018
5:00 PM CET
Publication of the Interim Report for the first nine months 2018
Sep 26, 2018 from 2:00 PM to 5:30 PM CEST
Genmab's Capital Markets Day, Utrecht, The Netherlands
Sep 12, 2018 from 2:15 PM to 2:45 PM EDT
Morgan Stanley Global Healthcare Conference, New York, US
Sep 12 - Sep 14, 2018
Bank of America Merrill Lynch Global Healthcare Conference 2018, London, UK
Aug 9, 2018
3:00 PM CEST
Interactive Q&A Session with Genmab's CEO
Aug 8, 2018
6:00 PM CEST
First Half 2018 Conference Call
Aug 8, 2018
5:00 PM CEST
Publication of the Interim Report for the first half 2018
Jun 19 - Jun 20, 2018
Citi 2018 European Healthcare Conference, London, UK
Jun 14 - Jun 17, 2018
23rd Congress of EHA, Stockholm, Sweden
Please see our download library for links to abstracts. 
Jun 12, 2018
4:00 PM PDT
Goldman Sachs 39th Annual Global Healthcare Conference, Rancho Palos Verdes, CA, US
Genmab President & CEO, Jan van de Winkel, Ph.D., will present a company update at the Goldman Sachs 39th Annual Global Healthcare Conference in Rancho Palos Verdes, California at 4:00 PM PDT on June 12, 2018 (1:00 AM CEST on June 13, 2018). 
Jun 1 - Jun 5, 2018
ASCO Annual Meeting, Chicago, IL, US
Please see our download library for links to abstracts. 
May 21 - May 23, 2018
UBS Global Healthcare Conference, New York, NY, US
May 9, 2018
5:00 PM CEST
Interactive Q&A Session with Genmab's CEO
May 9, 2018
Deutsche Bank's 43rd Annual Healthcare Conference, Boston, MA, US
May 8, 2018
6:00 PM CEST
First Quarter 2018 Conference Call
Apr 18, 2018
Kempen Life Sciences Conference, Amsterdam, The Netherlands
Apr 10, 2018
Annual General Meeting 2018
Feb 27, 2018
Credit Suisse Healthcare Conference, London, UK
Feb 26, 2018
Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors
Feb 22, 2018
4:00 PM CET
Interactive Q&A Session with Genmab's CEO
Feb 21, 2018
5:00 PM CET
Publication of the Annual Report for 2017
Jan 10, 2018
2:00 PM CET
36th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, US
CEO, Jan van de Winkel, Ph.D., will present a company update at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco at 2:00 PM PST on January 10, 2018 (11:00 PM CET).